Trendaavat aiheet
#
Bonk Eco continues to show strength amid $USELESS rally
#
Pump.fun to raise $1B token sale, traders speculating on airdrop
#
Boop.Fun leading the way with a new launchpad on Solana.
FDA sits on a treasure trove of data: past regulatory submissions, which often span tens of thousands of pages. These would be incredibly informative, but are locked away due to trade secret law. I propose leveraging AI & bankruptcy law to unleash this info &
empower start-ups.
12.8. klo 03.13
THE LAUNCH SEQUENCE
A new collection of 16 essays on how to accelerate AI for science & security:
The AI revolution is already delivering enormous consumer benefits. But AI progress won't automatically solve humanity's most important problems first. To get the future we want, we need to shape the trajectory of AI progress.
This series is a step toward that future…
My pitch is simple: at the moment, biotech startups have to navigate a regulatory process that they have extremely limited insight into. This favors incumbents & creates a "rent-seeking" system of overpriced consultants.
Past regulatory filings contain immense amounts of info; releasing them & training AI would increase transparency & speed drug development. This is legally complex due to trade secret law. Solution: set up a fund to buy these docs in the bankruptcy process of failed biotechs.
This is part of a broader push I co-started last year, the Clinical Trial Abundance Initiative, aimed at speeding up clinical trials, a major bottleneck in biotech. This has never been more important, as American biotechs are losing ground to China.
42,59K
Johtavat
Rankkaus
Suosikit